MCID for AOFAS Ankle Hindfoot Scale estimated at 4.1 to 7.8 points after ankle fracture surgery
This multicenter randomized controlled trial aimed to determine the minimal clinically important difference (MCID) for the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle Hindfoot Scale. The study enrolled 148 patients with surgically treated unstable ankle fractures and followed them for 12 months. Median AOFAS scores improved significantly from 73.0 at 3 months to 85.0 at 12 months postoperatively (p < 0.001).
The primary outcome was the MCID for the AOFAS score, calculated using multiple methods. Anchor-based methods produced MCID estimates of 7.1 for the 3- to 6-month interval and 7.8 for the 6- to 12-month interval using the mean change method, and 0.5 and 5.5 for the same intervals using ROC curve analysis. Distribution-based methods yielded estimates of 9.2 at 3 months, 8.2 at 6 months, and 7.1 at 12 months. The minimal detectable change (MDC) was 3.5 at 3 months, 2.8 at 6 months, and 4.1 at 12 months.
Safety and tolerability data were not reported. Key limitations include the inherent uncertainty in MCID estimation, as different calculation methods produced varying results. The study did not evaluate a specific surgical or rehabilitation intervention. The practice relevance is that a change in AOFAS score between 4.1 and 7.8 points may be considered clinically relevant at the 1-year follow-up, but clinicians should recognize the methodological variability in these estimates.